The global virus filtration market size was estimated at USD 4.26 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 10.1% from 2023 to 2030.

The rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is anticipated to propel the demand for biologics. According to the World Health Organization (WHO), around 422 million people globally are affected by diabetes. Rapid prevalence is observed in low- and middle-income nations compared to high-income nations. Amputation of the lower limbs is a common complication of diabetes, as are kidney disease, cardiac arrest, stroke, and blindness. According to the WHO, between 2000 and 2019, the mortality rates from diabetes rose by 3% for each age group and an estimated 2 million people died in 2019 from diabetes-related kidney disease.

Virus Filtration Market Segments

Product Insights

The consumables segment dominated the market with the largest revenue share in 2022 owing to the rising demand for these products for virus filtration. The demand for consumables such as reagents, kits, and membranes is anticipated to increase the production of vaccines, protein therapeutics, blood-related products, cellular therapy products, genetic therapy products, tissue products, and embryonic stem cell products.

Several leading vendors including Merck KGaA, Danaher, and Sartorius AG provide a broad range of reagents, kits, and other consumables for virus filtration. For instance, Merck offers a wide range of resins and media such as Eshmuno A Resin, ProSep Ultra Plus resin, ProSep-vA Ultra resin, ProSep-vA Ultra chromatography media, Eshmuno IEX Chromatography Resins, and Fractogel Ion Exchange Chromatography Resins.

Technology Insights

The filtration segment dominated the market with the largest revenue share in 2022 owing to the increased adoption of these products in the manufacturing of biologics and medical devices and research. Furthermore, it offers numerous benefits, including the preservation of protein integrity in both products and samples, along with the provision of excellent efficiency and purity in both laboratory and large-scale settings. Due to increased vendor R&D spending and product developments, the filtration segment is predicted to expand at a profitable rate during the forecast period.

End-use Insights

The biopharmaceutical and biotechnology companies segment dominated the virus filtration market with the largest revenue share in 2022 owing to increasing R&D activities, production of biologics, as well as growth in the biopharmaceutical industry. Increasing demand for innovative drugs and vaccines, advancements in scientific research and development, and supportive governmental schemes and policies are some of the drivers.

The CROs segment is expected to grow at the fastest CAGR over the forecast period, due to the trend of outsourcing R&D and manufacturing to CROs. An increase in the number of vaccines and therapeutic protein manufacturing companies has resulted in rising demand for outsourcing services that cater to the specific needs of these companies.

Application Insights

The biologicals segment held the largest revenue share of 56.6% in 2022 and is expected to grow at the fastest CAGR of 10.9% over the forecast period. This can be attributed to the rising prevalence of chronic diseases such as deficiency of growth hormones, blood disorders, cancer, diabetes, and autoimmune disorders that boost the demand for biologics. According to the World Health Organisation (WHO), 8.5% of individuals aged 18 and older had diabetes in 2014. 48% of the 1.5 million diabetes-related deaths that occurred in 2019 occurred in people under the age of 70.

Regional Insights

North America dominated the market with the largest revenue share of 41.2% in 2022. The established biotechnology and biopharmaceutical sectors in the U.S. have increased the region's demand for advanced viral clearance products for research and development and biologics manufacturing. 

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global whole genome sequencing market sizewas estimated at USD 2.12 billion in 2024 and is expected to grow at a CAGR of 22.17% from 2025 to 2030. 

• The global stem cells market sizewas estimated at USD 15.10 billion in 2024 and is expected to grow at a CAGR of 11.41% from 2025 to 2030.

Key Companies & Market Share Insights

The rise in competition is leading to rapid technological advancements and companies are constantly working towards the improvement of their products with a major focus on research and development. The market players are indulging themselves in the constant development of new and better virus filtration. Major manufacturers provide advanced products through strong distribution channels across the globe. For instance, Sartorius has a presence in more than 110 countries with around 30 sales offices and 20 manufacturing sites worldwide. Leading manufacturers are involved in mergers and acquisitions, strategic collaborations, and novel product development to gain revenue share in the industry.

Mergers and acquisitions help companies expand their existing businesses and geographical reach. For instance, in May 2022, AbbVie Inc., a pharmaceutical company based in the U.S., announced the acquisition of Allergan PLC, a pharmaceutical company involved in the marketing, manufacturing, development, and acquisition of medical devices and brand-name drugs.The acquisition promotes a substantial expansion and diversification of AbbVie Inc.'s revenue foundation, effectively complementing its current dominant presence in immunology through notable products such as Humira, Skyrizi, and Rinvoq, as well as in hematologic oncology with Imbruvica and Venclexta. Allergan brings forth fresh avenues for growth in the field of neuroscience, with its offerings such as Botox Therapeutics, Vraylar, and Ubrelvy, alongside an aesthetics business featuring renowned brands like Botox and Juvederm.

Some prominent players in the global virus filtration market include:

• Merck KGaA
• Danaher
• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Charles River Laboratories
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec
• Lonza
• Clean Biologics

Segments Covered in the Report

Grand View Research has segmented the global virus filtration market based on product, technology, application, end-use, and region:

Virus Filtration Product Outlook (Revenue, USD Million, 2018 - 2030)

• Consumables
  • Kits and Reagents
  • Others
• Instruments
  • Filtration Systems
  • Chromatography Systems
• Services

Virus Filtration Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Filtration
  • Consumables
  • Instruments
  • Services
• Chromatography
  • Consumables
  • Instruments
  • Services

Virus Filtration Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biologicals
  • Vaccines and Therapeutics
  • Blood and Blood Products
  • Cellular and Gene Therapy Products
  • Tissue and Tissue Products
  • Stem Cell Products
• Medical Devices
• Water Purification
• Air Purification

Virus Filtration End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Medical device companies
• Academic Institutes & Research Laboratories

Virus Filtration Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Order a free sample PDF of the Virus Filtration Market Intelligence Study, published by Grand View Research.